Skip to main content

EDITORIAL article

Front. Pharmacol.
Sec. Neuropharmacology
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1499072
This article is part of the Research Topic Reviews In Neuropharmacology 2023: Microbiota Gut-Brain Axis, Therapeutic Insights for Neurodegenerative Diseases View all 6 articles

Editorial: Reviews In Neuropharmacology 2023: Microbiota Gut-Brain Axis, Therapeutic Insights for Neurodegenerative Diseases

Provisionally accepted
Bhagavathi Sundaram Sivamaruthi Bhagavathi Sundaram Sivamaruthi 1*Suganthy Natarajan Suganthy Natarajan 2Carolina Pellegrini Carolina Pellegrini 3
  • 1 Chiang Mai University, Chiang Mai, Thailand
  • 2 Alagappa University, Karaikudi, Tamil Nadu, India
  • 3 University of Pisa, Pisa, Tuscany, Italy

The final, formatted version of the article will be published soon.

    Keywords: gut-brain axis, microbiota, Neurodegenerative Diseases, Probiotics, Alzheimer's disease, Parkinson's disease

    Received: 20 Sep 2024; Accepted: 24 Sep 2024.

    Copyright: © 2024 Sivamaruthi, Natarajan and Pellegrini. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Bhagavathi Sundaram Sivamaruthi, Chiang Mai University, Chiang Mai, Thailand

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.